{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:40:14Z","timestamp":1792878014374,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:00:00Z","timestamp":1607990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jhep.2020.12.010","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T05:15:29Z","timestamp":1608182129000},"page":"1416-1428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB\/c.Abcb4 mouse model of PFIC3"],"prefix":"10.1016","volume":"74","author":[{"given":"Guangyan","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingsong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinzhu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Disha","family":"Badlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kahini A.","family":"Vaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5439-7651","authenticated-orcid":false,"given":"David Q-H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Frassetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6550-6983","authenticated-orcid":false,"given":"Arianna","family":"Markel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6695-7102","authenticated-orcid":false,"given":"Vladimir","family":"Presnyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8265-7174","authenticated-orcid":false,"given":"Srujan","family":"Gandham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serenus","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lukacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick F.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6559-3308","authenticated-orcid":false,"given":"Paloma H.","family":"Giangrande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo G.V.","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7973-942X","authenticated-orcid":false,"given":"Yury V.","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2020.12.010_bib1","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1053\/gast.2001.23984","article-title":"The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood","volume":"120","author":"Jacquemin","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.12.010_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1055\/s-0038-1667299","article-title":"ABCB4 gene aberrations in human liver disease: an evolving spectrum","volume":"38","author":"Reichert","year":"2018","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2020.12.010_bib3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0030-1253223","article-title":"The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects","volume":"30","author":"Davit-Spraul","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2020.12.010_bib4","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.95.1.282","article-title":"Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis","volume":"95","author":"de Vree","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2020.12.010_bib5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","article-title":"Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease","volume":"75","author":"Smit","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2020.12.010_bib6","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.28300","article-title":"A\u00a0functional classification of ABCB4 variations causing progressive familial intrahepatic cholestasis type 3","volume":"63","author":"Delaunay","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.12.010_bib7","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1053\/j.gastro.2005.08.052","article-title":"Hepatocanalicular transport defects: pathophysiologic mechanisms of rare diseases","volume":"130","author":"Oude Elferink","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.12.010_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0031-1272831","article-title":"Progressive familial intrahepatic cholestasis (PFIC) type 1, 2, and 3: a review of the liver pathology findings","volume":"31","author":"Morotti","year":"2011","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2020.12.010_bib9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ncpgasthep0521","article-title":"Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis","volume":"3","author":"Beuers","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.12.010_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MPG.0b013e3181f50363","article-title":"Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations","volume":"52","author":"Colombo","year":"2011","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2020.12.010_bib11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/hep.510250303","article-title":"Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis","volume":"25","author":"Jacquemin","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.12.010_bib12","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1399-0012.2010.01368.x","article-title":"Progressive familial intrahepatic cholestasis: a single-center experience of living-donor liver transplantation during two decades in Japan","volume":"25","author":"Hori","year":"2011","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jhep.2020.12.010_bib13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev-med-122313-085916","article-title":"Lysosomal storage diseases: from pathophysiology to therapy","volume":"66","author":"Parenti","year":"2015","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jhep.2020.12.010_bib14","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1038\/s41467-019-13614-3","article-title":"Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model","volume":"10","author":"Weber","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2020.12.010_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2019.03.021","article-title":"Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice","volume":"71","author":"Aronson","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.12.010_bib16","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/hep.30773","article-title":"Prevention of Cholestatic liver disease and reduced tumorigenicity in a murine model of PFIC type 3 using hybrid AAV-piggyBac gene therapy","volume":"70","author":"Siew","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.12.010_bib17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2017.03.016","article-title":"Modified mRNA vaccines protect against Zika virus Infection","volume":"169","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2020.12.010_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat9143","article-title":"Durable anticancer immunity from intratumoral administration of IL-23, IL-36\u03b3, and OX40L mRNAs","volume":"11","author":"Hewitt","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2020.12.010_bib19","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.ymthe.2019.04.017","article-title":"mRNA therapy improves metabolic and behavioral abnormalities in a murine model of citrin deficiency","volume":"27","author":"Cao","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.jhep.2020.12.010_bib20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ajpath.2014.10.013","article-title":"A\u00a0new Mdr2(-\/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer","volume":"185","author":"Ikenaga","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2020.12.010_bib21","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ymthe.2018.03.010","article-title":"A\u00a0novel amino lipid series for mRNA delivery: improved endosomal escape and sustained pharmacology and safety in non-human primates","volume":"26","author":"Sabnis","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.jhep.2020.12.010_bib22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/hep.21591","article-title":"Bile salt-dependent efflux of cellular phospholipids mediated by ATP binding cassette protein B4","volume":"46","author":"Morita","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.12.010_bib23","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A\u00a0rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can J Biochem Physiol"},{"key":"10.1016\/j.jhep.2020.12.010_bib24","doi-asserted-by":"crossref","first-page":"G323","DOI":"10.1152\/ajpgi.00394.2009","article-title":"Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis","volume":"298","author":"Popov","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2020.12.010_bib25","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jhep.2005.06.025","article-title":"Mdr2 (Abcb4)-\/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes","volume":"43","author":"Popov","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.12.010_bib26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2007.11.021","article-title":"Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies","volume":"48","author":"Popov","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.12.010_bib27","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.molmed.2014.09.003","article-title":"A\u00a0critical analysis of codon optimization in human therapeutics","volume":"20","author":"Mauro","year":"2014","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jhep.2020.12.010_bib28","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1016\/j.celrep.2017.11.081","article-title":"Systemic messenger RNA therapy as a treatment for methylmalonic acidemia","volume":"21","author":"An","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhep.2020.12.010_bib29","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/s41591-018-0199-z","article-title":"Systemic messenger RNA as an etiological treatment for acute intermittent porphyria","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2020.12.010_bib30","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1053\/jhep.2002.33327","article-title":"Altered localization and activity of canalicular Mrp2 in estradiol-17beta-D-glucuronide-induced cholestasis","volume":"35","author":"Mottino","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.12.010_bib31","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2020.12.010_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hep.28274","article-title":"Integrin alphavbeta6 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis","volume":"63","author":"Peng","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.12.010_bib33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ajpath.2013.03.018","article-title":"Failure of fibrotic liver regeneration in mice is linked to a severe fibrogenic response driven by hepatic progenitor cell activation","volume":"183","author":"Kuramitsu","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2020.12.010_bib34","first-page":"1237","article-title":"Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis","volume":"145","author":"Mauad","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2020.12.010_bib35","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1055\/s-2001-19033","article-title":"Role of multidrug resistance 3 deficiency in pediatric and adult liver disease: one gene for three diseases","volume":"21","author":"Jacquemin","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2020.12.010_bib36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/gast.1996.v111.pm8698195","article-title":"Effects of ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene","volume":"111","author":"Van Nieuwkerk","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.12.010_bib37","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jhep.2017.04.026","article-title":"Biliary bile acids in hepatobiliary injury \u2013 what is the link?","volume":"67","author":"Fickert","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.12.010_bib38","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1089\/hum.2013.233","article-title":"Life-long correction of hyperbilirubinemia with a neonatal liver-specific AAV-mediated gene transfer in a lethal mouse model of Crigler-Najjar Syndrome","volume":"25","author":"Bortolussi","year":"2014","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jhep.2020.12.010_bib39","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/hep4.1084","article-title":"The ectonucleotidase ENTPD1\/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis","volume":"1","author":"Peng","year":"2017","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2020.12.010_bib40","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jhep.2009.01.014","article-title":"Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis","volume":"50","author":"Ripoll","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.12.010_bib41","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1053\/jhep.2003.50133","article-title":"Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis","volume":"37","author":"Abraldes","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.12.010_bib42","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics--developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jhep.2020.12.010_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2006-960172","article-title":"MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes","volume":"27","author":"Trauner","year":"2007","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2020.12.010_bib44","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.2741\/3526","article-title":"Liver diseases related to MDR3 (ABCB4) gene deficiency","volume":"14","author":"Gonzales","year":"2009","journal-title":"Front Biosci (Landmark Ed"},{"key":"10.1016\/j.jhep.2020.12.010_bib45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.gastro.2008.03.044","article-title":"ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults","volume":"135","author":"Ziol","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.12.010_bib46","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jhep.2019.01.036","article-title":"Clinical utility of genomic analysis in adults with idiopathic liver disease","volume":"70","author":"Hakim","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.12.010_bib47","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/ng.3247","article-title":"Large-scale whole-genome sequencing of the Icelandic population","volume":"47","author":"Gudbjartsson","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2020.12.010_bib48","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.29100","article-title":"The ABCB4 p.T175A variant as potential modulator of hepatic fibrosis in patients with chronic liver diseases: looking beyond the cholestatic realm","volume":"66","author":"Krawczyk","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.12.010_bib49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.fpc.0000230418.28091.76","article-title":"Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury","volume":"17","author":"Lang","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jhep.2020.12.010_bib50","doi-asserted-by":"crossref","first-page":"23530","DOI":"10.1074\/jbc.M909002199","article-title":"MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping","volume":"275","author":"Smith","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhep.2020.12.010_bib51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2006-960172","article-title":"MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes","volume":"27","author":"Trauner","year":"2007","journal-title":"Semin Liver Dis"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820338496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820338496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:39:58Z","timestamp":1759174798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827820338496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0168827820338496"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2020.12.010","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB\/c.Abcb4-\/- mouse model of PFIC3","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2020.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association for the Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}